Skip to main content
. 2021 Oct 22;107(3):e1136–e1147. doi: 10.1210/clinem/dgab750

Table 2.

Changes from baseline to last visit in predefined outcomes

Baseline mean (SD) Last visit mean (SD) Mean change (95% CI) P value
Primary outcome
T3, nmol/L (n = 67) 4.58 (1.11) 1.66 (0.69) −2.92 (−3.23 to −2.61) <0.0001
Secondary outcomes
Anthropometric parameters and heart rate
Body weight, kg (n = 58) 17.8 (12.1) 23.6 (14.5) 5.7 (4.2 to 7.2)
Weight-for-age Z-score (n = 58) −2.81 (1.94) −2.64 (1.81) 0.17 (−0.18 to 0.53) 0.3263
Δ Weight-for-age—predicted weight-for-age Z-score (n = 55) 0.07 (1.83) 0.79 (1.92) 0.72 (0.36 to 1.09) 0.0002
Height, cm (n = 44) 101 (21) 116 (23) 15 (12 to 19)
Height-for-age Z-score (n = 44) −1.84 (1.77) −1.92 (1.51) −0.09 (−0.50 to 0.32) 0.6705
Δ Height-for-age—predicted height-for-age Z-score (n = 43) −0.44 (1.38) 0.14 (1.41) 0.58 (0.12 to 1.05) 0.0139
Weight-for-height Z-score (n = 44) −2.02 (2.49) −1.50 (2.44) 0.52 (−0.35 to 1.39) 0.2358
Heart rate, bpm (n = 48) 113 (21) 97 (20) −17 (−24 to −10) <0.0001
Heart rate-for-age Z-score (n = 48) 1.59 (0.89) 0.96 (1.01) −0.64 (− 0.98 to −0.29) 0.0005
Thyroid function tests
TSH, mU/L (n = 62)* 3.32 (2.30) 0.95 (0.73) −2.38 (−2.98 to −1.77) <0.0001
Free T4, pmol/L (n = 64) 9.5 (2.3) 3.4 (1.6) −6.1 (−6.7 to −5.4) <0.0001
T4, nmol/L (n = 63) 54.2 (11.8) 18.1 (9.8) −36.1 (−39.5 to −32.7) <0.0001
Peripheral markers
Sex hormone-binding globulin, nmol/L (n = 48) 245 (99) 209 (92) −36 (−57 to −16) 0.0008
Creatinine, µmol/L (n = 47) 32 (11) 39 (13) 7 (6 to 9) <0.0001
Creatine kinase, U/L (n = 47)* 110 (87) 128 (80) 18 (−8 to 45) 0.2166

All outcomes were assessed in all patients who received Triac treatment longer than the mean time to optimal dose (5.0 months; N = 64). Data are mean. Body weight-for-age Z-scores were calculated using TNO growth calculator and heart rate-for-age Z-scores were calculated using the Boston Z-score calculator. Abbreviations: bpm, beats per minute; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone.

*TSH and creatine kinase concentrations were log-transformed to ensure a normal distribution before paired t tests were done (nontransformed means [SD] and mean changes [95% CI] are presented for the sake of interpretability).